
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

June 2, 2023
Data submissions are very regulated, but every drug and drug development are different. Therefore, the data presented...
Read article

May 24, 2023
It’s Time to Move, Time to Move to Define-XML 2.1
As of March 2023, specifically for any study started on or after March 15, 2023,1 for the submission of SEND, SDTM, and...
Read article

October 14, 2022
Career Perspectives: A Conversation with Nicolas Rouillé
In this edition of the Career Perspectives series, I interview Nicolas Rouillé, Senior Director, Statistical...
Read article

January 13, 2021
How to Create a High-Quality Globally Distributed Biometrics Team?
Effective use of the right outsourcing solution can enable sponsors to respond to market needs and change course where...
Read article

September 1, 2020
FSP Navigator – Building the Team that Brings Success
In this blog, Cytel's SVP Corey Dunham’s talks about our Functional Services teams and the qualities we seek in new...
Read article

July 14, 2020
The FSP Engagement Landscape: Reducing Sponsor Oversight Burden
Cytel SVP Corey Dunham’s inaugural post on leading the industry’s largest Biometrics CRO considers the FSP Engagement...
Read article